Elizabeth C. Wright

18.9k total citations · 4 hit papers
185 papers, 13.8k citations indexed

About

Elizabeth C. Wright is a scholar working on Epidemiology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elizabeth C. Wright has authored 185 papers receiving a total of 13.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Epidemiology, 63 papers in Hepatology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elizabeth C. Wright's work include Hepatitis C virus research (55 papers), Liver Disease Diagnosis and Treatment (51 papers) and Hepatitis B Virus Studies (29 papers). Elizabeth C. Wright is often cited by papers focused on Hepatitis C virus research (55 papers), Liver Disease Diagnosis and Treatment (51 papers) and Hepatitis B Virus Studies (29 papers). Elizabeth C. Wright collaborates with scholars based in United States, United Kingdom and Canada. Elizabeth C. Wright's co-authors include Herbert L. Bonkovsky, Timothy R. Morgan, Nicholas R. Anthonisen, Anna S. Lok, Jules L. Dienstag, Adrian M. Di Bisceglie, Leonard B. Seeff, William M. Lee, James E. Everhart and Karen L. Lindsay and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Elizabeth C. Wright

180 papers receiving 13.1k citations

Hit Papers

Long-term Effects of Cognitive Training on Eve... 1989 2026 2001 2013 2006 1992 2011 1989 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-term Effects of Cognitive Training on Everyday Functional Outcomes in Older Adults
    2006 1.1k citations Sharon L. Tennstedt, Frederick W. Unverzagt et al. profile →
  2. Long-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
    1992 570 citations Leonard B. Seeff, Elizabeth C. Wright et al. profile →
  3. Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling
    2011 553 citations Hariom Yadav, Celia Quijano et al. Cell Metabolism profile →
  4. Body Weight in Chronic Obstructive Pulmonary Disease: The National Institutes of Health Intermittent Positive-Pressure Breathing Trial
    1989 385 citations Elizabeth C. Wright et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth C. Wright United States 62 5.1k 4.4k 2.1k 1.8k 1.8k 185 13.8k
David A. Roth United States 47 2.0k 0.4× 1.2k 0.3× 2.9k 1.4× 1.3k 0.7× 700 0.4× 212 20.6k
Sherine E. Gabriel United States 76 2.6k 0.5× 1.3k 0.3× 3.7k 1.8× 2.0k 1.1× 1.9k 1.1× 202 29.3k
Deborah Symmons United Kingdom 87 2.4k 0.5× 978 0.2× 1.3k 0.6× 1.3k 0.7× 2.3k 1.3× 396 27.2k
Kiyoshi Kurokawa Japan 75 2.2k 0.4× 1.5k 0.3× 2.3k 1.1× 2.7k 1.5× 475 0.3× 522 22.6k
John Horton United States 35 2.0k 0.4× 686 0.2× 5.2k 2.4× 2.2k 1.2× 2.7k 1.5× 104 16.7k
Kenneth G. Saag United States 86 2.7k 0.5× 838 0.2× 1.2k 0.5× 1.4k 0.8× 796 0.5× 476 26.7k
Dafna D. Gladman Canada 102 2.3k 0.5× 1.2k 0.3× 1.0k 0.5× 1.2k 0.7× 734 0.4× 959 47.9k
Theodore Pincus United States 82 1.5k 0.3× 836 0.2× 774 0.4× 1.1k 0.6× 1.7k 0.9× 421 25.6k
Anders Ekbom Sweden 66 5.2k 1.0× 1.1k 0.3× 1.9k 0.9× 693 0.4× 330 0.2× 204 16.2k
Josef S Smolen Austria 89 2.1k 0.4× 735 0.2× 1.2k 0.6× 1.0k 0.6× 4.0k 2.2× 509 35.4k

Countries citing papers authored by Elizabeth C. Wright

Since Specialization
Citations

This map shows the geographic impact of Elizabeth C. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth C. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth C. Wright more than expected).

Fields of papers citing papers by Elizabeth C. Wright

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth C. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth C. Wright. The network helps show where Elizabeth C. Wright may publish in the future.

Co-authorship network of co-authors of Elizabeth C. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth C. Wright. A scholar is included among the top collaborators of Elizabeth C. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth C. Wright. Elizabeth C. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Livinski, Alicia A., Elizabeth C. Wright, Tacy Downing, et al.. (2024). Meta‐analysis: Incidence of cirrhosis and hepatocellular carcinoma in patients with Fontan palliation. Alimentary Pharmacology & Therapeutics. 59(9). 1020–1032. 2 indexed citations
2.
Choate, Radmila, et al.. (2024). Financial Toxicity in Patients With Chronic Pancreatitis. Pancreas. 53(9). e774–e779. 2 indexed citations
3.
4.
Blau, Jenny E., Viviana Bauman, Paolo Piaggi, et al.. (2018). Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study. JCI Insight. 3(8). 118 indexed citations
5.
Yadav, Hariom, Celia Quijano, Anil K. Kamaraju, et al.. (2011). Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling. Cell Metabolism. 14(1). 67–79. 553 indexed citations breakdown →
6.
Freedman, Neal D., Teresa M. Curto, Karen L. Lindsay, et al.. (2011). Coffee Consumption Is Associated With Response to Peginterferon and Ribavirin Therapy in Patients With Chronic Hepatitis C. Gastroenterology. 140(7). 1961–1969. 47 indexed citations
7.
Leelahavanichkul, Asada, Yan Qin, Xuzhen Hu, et al.. (2010). Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney International. 78(11). 1136–1153. 137 indexed citations
8.
Shiffman, Mitchell L., Chihiro Morishima, Jules L. Dienstag, et al.. (2009). Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial. Gastroenterology. 137(6). 1986–1994. 30 indexed citations
9.
Lindsay, Karen L., Chihiro Morishima, Elizabeth C. Wright, et al.. (2008). Blunted Cytopenias and Weight Loss: New Correlates of Virologic Null Response to Re-treatment of Chronic Hepatitis C. Clinical Gastroenterology and Hepatology. 6(2). 234–241. 22 indexed citations
10.
Morishima, Chihiro, Timothy R. Morgan, James E. Everhart, et al.. (2008). Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction–negative samples obtained after treatment of chronic hepatitis C. Hepatology. 48(5). 1412–1419. 17 indexed citations
11.
Fontana, Robert J., Linas A. Bieliauskas, Karen L. Lindsay, et al.. (2007). Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C†‡. Hepatology. 45(5). 1154–1163. 31 indexed citations
12.
Wolinsky, Fredric D., Frederick W. Unverzagt, David M. Smith, et al.. (2006). The Effects of the ACTIVE Cognitive Training Trial on Clinically Relevant Declines in Health-Related Quality of Life. The Journals of Gerontology Series B. 61(5). S281–S287. 115 indexed citations
13.
Yeh, Matthew M., et al.. (2005). More Severe Parenchymal Injury in Chronic Hepatitis C Acquired by Recent Injection Drug Use. Journal of Clinical Gastroenterology. 39(8). 722–727. 3 indexed citations
14.
Wright, Elizabeth C.. (2004). Assessment and management of the child requiring chronic haemodialysis. Paediatric Care. 16(7). 37–41. 3 indexed citations
15.
Hsu, Lewis L., Scott T. Miller, Elizabeth C. Wright, et al.. (2003). Alpha Thalassemia is Associated With Decreased Risk of Abnormal Transcranial Doppler Ultrasonography in Children With Sickle Cell Anemia. Journal of Pediatric Hematology/Oncology. 25(8). 622–628. 84 indexed citations
16.
Strader, Doris B., Bruce R. Bacon, Karen L. Lindsay, et al.. (2002). Use of complementary and alternative medicine in patients with liver disease. The American Journal of Gastroenterology. 97(9). 2391–2397. 129 indexed citations
17.
Phipatanakul, Wanda, Peyton A. Eggleston, Elizabeth C. Wright, & Robert A. Wood. (2000). Mouse allergen. II. The relationship of mouse allergen exposure to mouse sensitization and asthma morbidity in inner-city children with asthma. Journal of Allergy and Clinical Immunology. 106(6). 1075–1080. 172 indexed citations
18.
Wright, Linda L., Roger F. Soll, Elizabeth C. Wright, et al.. (1993). A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome1. The Journal of Pediatrics. 123(5). 757–766. 124 indexed citations
19.
Dhillon, Baljean, Elizabeth C. Wright, & Brian W. Fleck. (1993). Screening for Retinopathy of Prematurity: Are a Lid Speculum and Scleral Indentation Necessary?. Journal of Pediatric Ophthalmology & Strabismus. 30(6). 377–381. 13 indexed citations
20.
Fleck, Brian W., et al.. (1991). Argon Laser Pretreatment 4 to 6 Weeks Before Nd:YAG Laser Iridotomy. Ophthalmic surgery, lasers & imaging retina. 22(11). 644–649. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Roth Breakdown of academic impact, for papers by Sherine E. Gabriel Breakdown of academic impact, for papers by Deborah Symmons Breakdown of academic impact, for papers by Kiyoshi Kurokawa Breakdown of academic impact, for papers by John Horton Breakdown of academic impact, for papers by Kenneth G. Saag Breakdown of academic impact, for papers by Dafna D. Gladman Breakdown of academic impact, for papers by Theodore Pincus Breakdown of academic impact, for papers by Anders Ekbom Breakdown of academic impact, for papers by Josef S Smolen
Rankless by CCL
2026